Tablets Manufacturing Methods and Granulation Techniques
		
                    
                                 Sravya I*
Department of Biotechnology , Gokaraju Rangaraju Institute of Engineering and Technology, Hyderabad, Telangana, India 
  - *Corresponding Author:
- Sravya I  
 Department of Biotechnology
 Gokaraju Rangaraju Institute of Engineering and Technology
 Hyderabad, Telangana, India
 Email: sravyai49@gmail.com
Received date: 26/09/2016; Accepted date: 28/09/2016; Published date: 30/09/2016
                Visit for more related articles at Research & Reviews: Journal of Pharmacology and Toxicological Studies
         
        
        
                Abstract
        From past hundred years tablet manufacturers have developed materials and processes that can produce compressed tablets containing a precise amount of an active pharmaceutical ingredient (API) at high speed and at relatively low cost. Granulation may be defined as a size enlargement process which converts small particles into physically stronger & larger agglomerates
                Keywords
Granulation, Tablet machine, Lubricant
Introduction
Granulation method can be broadly classified into two types: Wet granulation and Dry granulation.
Wet Granulation
The most widely used process of agglomeration [1-7] in pharmaceutical industry is wet granulation. Wet granulation process simply involves wet massing [8-15] of the powder blend with a granulating liquid, wet sizing and drying.
Important steps involved in the wet granulation
i) Mixing of the drug(s) and excipients.
  ii) Preparation of binder solution.
  iii) Mixing of binder solution with powder mixture to form wet mass [16-18].
  iv) Drying of moist granules.
  v) Mixing of screened granules with disintegrant, glidant, and lubricant. 
Advantages
 a) Permits mechanical handling of powders without loss of mix quality.
  b) Improves the flow of powders by increasing particle size and sphericity [19-23].
  c) Increases and improves the uniformity of powder density.
Limitation of wet granulation
i) The greatest disadvantage of wet granulation [24-28] is its cost. It is an expensive process because of labor, time, equipment, energy and space requirements.
  ii) Loss of material during various stages of processing.
Dry Granulation
In dry granulation process the powder mixture is compressed without the use of heat and solvent. It is the least desirable of all methods of granulation [29-33]. The two basic procedures are to form a compact of material by compression and then to mill the compact to obtain a granules. Two methods are used for dry granulation [34-37]. The more widely used method is slugging, where the powder is recompressed and the resulting tablet or slug are milled to yield the granules [38-42]. The other method is to recompress the powder with pressure rolls using a machine such as Chilosonator.
Rollar Compaction
The compaction of powder by means of pressure roll can also be accomplished by a machine called chilsonator. Unlike tablet machine, the chilsonator [42-48] turns out a compacted mass in a steady continuous flow. The powder is fed down between the rollers from the hopper which contains a spiral auger to feed the powder into the compaction zone. Like slugs, the aggregates are screened or milled for production into granules [49-56].
  Use: Use in the production of directly compressible excipients, the compaction of drugs and drug formulations, the granulation of inorganic materials, the granulation of dry herbal material [57-62] and the production of immediate/sustained release formulations.
Advancement in Granulations
Steam Granulation
It is modification of wet granulation. Here steam is used as a binder instead of water. Its several benefits includes higher distribution uniformity, higher diffusion rate into powders, more favourable thermal balance [63-67] during drying step, steam granules are more spherical, have large surface area hence increased dissolution rate of the drug from granules, processing time [68-72] is shorter therefore more number of tablets are produced per batch, compared to the use of organic solvent water vapour is environmentally friendly, no health hazards to operators, no restriction by ICH on traces left in the granules, freshly distilled steam is sterile and therefore the total count can be kept under control, lowers dissolution rate so can be used for preparation of taste masked granules without modifying availability of the drug [73-80].
Melt Granulation / Thermoplastic Granulation
Here granulation is achieved by the addition of moldable binder [81-84]. That is binder is in solid state at room temperature but melts in the temperature range of 50 – 80˚C. Melted binder then acts like a binding liquid. There is no need of drying phase since dried granules are obtained by cooling it to room temperature [85-90].
Foam Granulation
Here liquid binders are added as aqueous foam. It has several benefits over spray(wet) granulation such as it requires less binder than Spray Granulation, requires less water to wet granulate [91-92], rate of addition of foam is greater than rate of addition of sprayed liquids, no detrimental effects on granulate, tablet, or in vitro drug dissolution properties, no plugging problems since use of spray nozzles is eliminated, no over wetting, useful for granulating water sensitive formulations, reduces drying time, uniform distribution of binder throughout the powder bed, reduce manufacturing time [93-94], less binder required for Immediate Release (IR) and Controlled Release (CR) formulations.
Conclusion
Direct Compressible Excipients, which can be used universally with any of the APIs, can lead to a revolution in tablet manufacturing techniques by way of low cost and efficient tablet manufacturing [95-98]. These economic advantages will be beneficial for both manufacturing and consumer, we can also go for certain synthetic but inert materials, and by using them we can produce tablets using ingredients than otherwise could not possibly be compressed to a tablet. This indicates that dry granulation produces granules [99-100] with good flow properties and that by direct compression are fair in grading.
References
  - ShimodairaS,et  al. Quality Verification of Dendritic Cell-Based Cancer Vaccine. Pharm Anal  Acta. 2016;7:465.
- Hassali MA,  et al. Role of Pharmacists in Health Based Non-Governmental Organizations NGO:  Prospects and Future Directions. Pharm Anal Acta. 2016;7:467.
- Vergeire-Dalmacion  G. Usefulness of Cost Effectiveness: Evidence versus Applicability. Pharm Anal  Acta 2016;7:456.
- Wang C.  Application of In Vitro Models in Developmental Neurotoxicity and Pharmaceutics  Research. J Mol Pharm Org Process Res.2015;3:e122.
- Lyubchenko  YL. Nanoimaging for Molecular Pharmaceutics of Alzheimer’s and other  Neurodegenerative Disorders. J Mol Pharm Org Process Res. 2013;1:e107.
- Skalko-Basnet  N. Note on the “Molecular Pharmaceutics and Organic Process”. J Mol Pharm Org  Process Res. 2013;1:e104.
- Foldvari M.  Nanopharmaceutics Innovations in Gene Therapy: Moving Towards Non-Viral and  Non-Invasive Delivery Methods. J NanomedineBiotherapeuticDiscov. 2014;4:e135.
- Qumbar M, et  al. DOEBased Stability Indicating RP-HPLC Method for Determination of  Lacidipine in Niosomal Gel in Rat: Pharmacokinetic Determination. Pharm Anal  Acta. 2014;5:314.
- Abbas-Aksil  T, et al. Matrix Tablets from Algerian Lyophilized Berries LB Arbutus unedo L.  Date Phoenix dactylifera L.0020Nat Prod Chem Res. 2016;4:207.
- Oshizumi Y et  al. Dynamics of Swallowing Tablets during the Recovery Period following Surgery  for Tongue Cancer. Otolaryngology. 2016;6:218.
- Kubo Y, et  al. Interventional Evaluation of  MonoammoniumGlycyrrhizinate-Glycine/DLMethionine Combination Tablets in Mild  Alopecia Areata. J ClinExpDermatol. 2016;Res7:322.
- Belafkih B,  etal.LCMS/ MS Analysis of MDMA in Ecstasy Tablets in Morocco. J Forensic  Res.2015;6:301.
- Vargas M, et  al. Bioequivalence Study of Two Formulations Containing Rosuvastatin 40 Mg  Tablets in Healthy Colombians. J BioequivAvailab. 2015;7:229-232.
- Bustami, R et  al. Bioequivalence of Losartan/Amlodipine Fixed Dose Combination Tablets  Losanet AM Compared with Concomitant Administration of Single Components of  Losartan and Amlodipine Tablets in Healthy Human Volunteers. J BioequivAvailab.  2015;7:216-224.
- Vargas M,  etal.Fed and Fasting Bioequivalence Study for Two Formulations of Bosentan 125  Mg Tablets in Healthy Colombian People. J BioequivAvailab. 2015;7:210-215.
- Muñoz E, et  al. Bioequivalence Study of Two Formulations of Escitalopram Oxalate 20 mg  Tablets in Healthy Volunteers. J Bioequiv Availab.2015;7:205-209.
- Sallam A, et  al. Bioequivalence of Two Oral Formulations of Modafinil Tablets in Healthy  Male Subjects under Fed and Fasting Conditions. J BioequivAvailab.  2015;7:063-067.
- Agatonovic-Kustrin  S, et al. Biorelevant Dissolution Studies of Pioglitazone HCL Immediate Release  Tablets and the Determination of an In Vitro In Vivo Correlation. J  BioequivAvailab. 2015;7:086-089.
- Damodar R, et  al. Formulation and Evaluation of Fast Dissolving Tablets of Diclofenac Sodium  by Novel Hole Technology. J Mol Pharm Org Process Res. 2014;2:116.
- Malhotra B,  et al. Relative Bioavailability Study of an Abuse-Deterrent Formulation of  Extended-Release Oxycodone with Sequestered Naltrexone ALO-02 Versus  Immediate-Release Oxycodone Tablets in Healthy Volunteers. J BioequivAvailab.  2014;6:186-191.
- Zhang X and  Zhang S. Bioequivalence Study of Two 30 Mg Tolvaptan Tablets Formulations in  Healthy Chinese under Fed Condition. J BioequivAvailab. 2014;6:181-185.
- Devineni D,  et al. Bioequivalence of Canagliflozin/Metformin Immediate Release Fixed-Dose  Combination Tablets Compared with Concomitant Administration of Single  Components of Canagliflozin and Metformin in Healthy Fed Participants. J  BioequivAvailab. 2014;6:164-173.
- Kumari KP, et  al. Stability Indicating RP-HPLC method Development and Validation of Salicylic  Acid in Choline Magnesium TrisalicilateTrilisate Tablets. J Pharma Care Health  Sys. 2014;1:120.
- Kassem MA and  El-Sayed GO. Adsorption of Tartrazine on Medical Activated Charcoal Tablets  under Controlled Conditions. J Environ Anal Chem. 2014;1:102.
- deFigueiredo  NB, et al. Determination of 3,4-methylenedioxymethamphetamine MDMA in  Confiscated Tablets by High-Performance Liquid Chromatography HPLC with Diode  Array Detector. J Forensic Res. 2010;1:106.
- Damodar R, et  al. Role of Novel Hole Technology in Fast Dissolving Tablets. J Mol Pharm Org  Process Res. 2014;2:R1-001.
- Friedrich C,  et al. Bioequivalence of Glucophage® Metformin Tablets from Europe and the  United States Tested in Healthy Volunteers. J BioequivAvailab. 2014;6:061-066.
- Salem H, et  al. Simultaneous Determination of Omeprazole, Tinidazole and Clarithromycin in  Bulk Powder and Helicure® Tablets by HPLC. J Chromatograph SeparatTechniq.  2014;5:221.
- Abdul Althaf  S, et al. Formulation, Evaluation and Mathematical Modelling of  ClopidogrelBisulphate& Aspirin Immediate Release Bilayer Tablets.  Pharmaceut Anal Acta.2012;3:194.
- Biswas D and  Halquist M. Using Biorelevant in Vitro Models Testing to Characterize Release  of Non Oral Dosage Forms as another Tool for Safety. J Pharmacovigil.  2016;4:e153.
- Bhattacharjee  J. Mass Drugs Administration in India - A Failure Story. Epidemiology  (Sunnyvale). 2016;6:252.
- Swain S and  Beg S. Emergence in the Lipid-Based Nanostructured Systems for Optimizing Oral  Delivery of Drugs. PharmaceutReg Affairs. 2016;5:e157.
- Maia Campos  PMBG et al. An Oral Supplementation Based on Hydrolyzed Collagen and Vitamins  Improves Skin Elasticity and Dermis Echogenicity: A Clinical Placebo-Controlled  Study. ClinPharmacolBiopharm. 2015;4:142.
- Gelaw BK, et  al. Prescription Pattern of Injection at Out Patient Pharmacy Department of  Adama Hospital Medical College, Adama, Ethiopia. ClinPharmacolBiopharm.  2015;4:146.
- Kokardekar  RR, et al. Development and Evaluation of Sustained Release Microspheres of  Glibenclamide by Emulsion Solvent Evaporation Method. ClinPharmacolBiopharm.  2014;3:127.
- Cho SK. The  Synergistic Effects of Pioglitazone on the Glucose-Lowering Action of Metformin  in Relation to OCT1 and Gluts m-RNA Expression in Healthy Volunteer.  ClinPharmacolBiopharm. 2015;3:129.
- Ehrenpreis  ED, etal.A Survey of Lawsuits Filed for the Complaint of Tardive Dyskinesia  Following Treatment with Metoclopramide. ClinPharmacolBiopharm. 2015;4:131.
- Adnan M,et  al. Evaluation of Self-Medication Practices and Awareness among Students in Al  Qassim Region of Saudi Arabia. ClinPharmacolBiopharm. 2015;4:133.
- Reure J, et  al. Her2 Positive Metastatic Breast Cancer Patient without Any Sign of  Recurrence 5 years after Cessation of Trastuzumab: A Case Report  ClinPharmacolBiopharm. 2015;4:136.
- Gavasane AJ  and Pawar HA.  Synthetic Biodegradable  Polymers Used in Controlled Drug Delivery System: An Overview.  ClinPharmacolBiopharm. 2014;3:121.
- Aghahowa SE,  et al.Tolerabilities of Artemisinin-Based Combination Drugs among Patients with  Uncomplicated Malaria in a Tertiary Institution Benin City, Nigeria.  ClinPharmacolBiopharm. 2014;3:123.
- De Wolf J, et  al. Evolution of Drug Utilization in Nursing Homes in Belgium.  ClinPharmacolBiopharm. 2014;3:124.
- González  EM,et al. In Vitro Antioxidant Capacity of Crude Extracts and Acetogenin  Fraction of Soursop Fruit Pulp. Pharm Anal Acta.2016;7:484.
- Permender R,  et al. Novel Statistically Designed Qbd Methodology for Quantitative Analysis  of Nisoldipine in Pharmaceutical Dosage Forms. Pharm Anal Acta. 2016;7:489.
- Abass SAE, et  al.Development and Validation of Spectrophotometric and Pre-column  Derivatization HPLC Method for Determination of Famotidine in Pharmaceuticals  by Reaction with Sodium Nitroprusside; Application to Combined Tablets. Pharm  Anal Acta.2016;7:476.
- Ranjna C,  etal.Pharmaceutical Analysis and the Growing Disciplines. Pharm Anal Acta.  2016;7:478.
- Sohel D,  etal.Bioavailability Study of Sustain Release Preparations of Three Widely used  NSAIDS Available in Bangladesh. Pharm Anal Acta.2016;7:482.
- Lee S, et al.  Lifetime Assessment of POCT Strips through Accelerated Degradation Test. Pharm  Anal Acta. 2016;7:475.
- Kogawa AC, et  al. Quantification of Doxycycline in Raw Material by an Eco-Friendly Method of  Infrared Spectroscopy. Pharm Anal Acta. 2016;7:463.
- Swain S.  Mucoadhesive Micro and Nanoparticles for Oral Controlled Drug Delivery System  for Prolongation of Gastric Residence and Its Application. PharmaceutReg  Affairs. 2012;1:e115.
- James  Kirkpatrick C, et al. Non-Equivalence of Antibiotic Generic Drugs and Risk for  Intensive Care Patients. PharmaceutReg Affairs. 2013;2:109.
- Swain S and  Mishra SS. Drug Regulatory Affairs in Quality Management. PharmaceutReg  Affairs. 2014; 3:e132.
- Su K, et al.  Preparation of Polymeric Micelles of Curcumin with Pluronic P123 and Assessment  of Efficacy against B16 Cells In vitro. AdvPharmacoepidemiol Drug Saf. 2016 ;  5:202.
- Péron E, et  al. Selective Serotonin Reuptake Inhibitors, are They All Equal? A  Pharmacoepidemiological Study. AdvPharmacoepidemiol Drug Saf. 2016;5:203.
- Lu DY, et al.  Anticancer Drug Combinations, Studies for All Possibilities.  AdvPharmacoepidemiol Drug Saf. 2016;5:138.
- PatilJS.Significance  of Particulate Drug Delivery System in Antimicrobial Therapy.  AdvPharmacoepidemiol Drug Saf. 2016;5:139.
- Alomi YA. National  Drug Information Center Program at Ministry of Health in Saudi Arabia.  AdvPharmacoepidemiol Drug Saf. 2016;5:140.
- Alomi YA, et  al. National Drug Information Center Services through Ministry of Health  Hotline Calling Center 937 in Saudi Arabia. AdvPharmacoepidemiol Drug Saf.  2016;5:198.
- Patil JS.  Hydrogel System: An Approach for Drug Delivery Modulation. AdvPharmacoepidemiol  Drug Saf. 2015;4:e135.
- Patil JS.  Novel Tubercular Therapeutic Agents: Need of the Day. AdvPharmacoepidemiol Drug  Saf.2015; 4:e137.
- Obara T, et  al. Prevalence, Determinants, and Reasons for the Non-Reporting of Adverse Drug  Reactions by Pharmacists in the Miyagi and Hokkaido Regions of Japan.  AdvPharmacoepidemiol Drug Saf. 2015;4:191.
- Teoh BC, et  al. Perceptions of Doctors and Pharmacists towards Medication Error Reporting  and Prevention in Kedah, Malaysia: A Rasch Model Analysis. AdvPharmacoepidemiol  Drug Saf. 2015;4:192.
- Vitale G, et  al. Development of Psychiatric Symptoms during Antiviral Therapy for Chronic  Hepatitis C. AdvPharmacoepidemiol Drug Saf. 2015;4:193.
- Oliveira L  and Santos Z. Use of Psychotropics and Drug-Drug Interactions in Oncology:  Reflections from a Study in a Portuguese Psycho- Oncology Unit.  AdvPharmacoepidemiol Drug Saf. 2015;4:194.
- Rompikuntal  PK and Garlapati S. Antimicrobial Drug Resistance. AdvPharmacoepidem Drug  Safety. 2015;S2:001.
- Tutar Y.  Diazepine Derivative Compounds as Heat Shock Protein 90 Inhibitor in Oncology.  Drug Des. .2015;4:e127.
- Kalaiselvan  V, et al. Indian Pharmacopoeia Commission's Partners for Promoting Public  Health. AdvPharmacoepidemiol Drug Saf. 2015;4:181.
- Kalaivani M,  et al. Direct Consumer Reporting of ADRs to PvPI, a Position Paper of Indian  Pharmacopoeia Commission. AdvPharmacoepidemiol Drug Saf.2015;4:184.
- IJff DM, et  al. Subjectively Perceived Side-Effects of Anti-Epileptic Drugs in Chronic  Refractory Epilepsy. AdvPharmacoepidemiol Drug Saf. 2015;4:186.
- Kumar N, Jha  A.  Regulatory Approach to Ensure Quality  of Products-An Indian Perspective of Missing Linkage. PharmaceutReg Affairs. 2016;5:163.
- Abdul Althaf  S, et al. Formulation, Evaluation and Mathematical Modelling of  ClopidogrelBisulphate& Aspirin Immediate Release Bilayer Tablets.  Pharmaceut Anal Acta.2012;3:194.
- Lokesh PNV,  et al. Design, Development and Formulation of Orodispersible Tablets of a Model  Drug Using Response Surface Methodology. Pharmaceut Anal Acta. 2012;3:195.
- Kaale E, et  al. The Development and Validation of a Thin Layer Chromatography Densitometry  Method for the Analysis of Diclofenac Sodium Tablets. Pharmaceut Anal  Acta.2013;4:202.
- Bhoya PN, et  al. Development and Validation of TLC-Densitometry Method for Simultaneous  Estimation of BisoprololFumarate and Hydrochlorothiazide in Bulk and Tablets. J  Chromat Separation Techniq. 2012;4:163.
- Menon S, et  al. Bioequivalence and Pharmacokinetic Evaluation of Two Formulations of  Armodafinil 250 mg Tablets in Healthy Indian Adult Male Subjects. J Bioequiv  Availab.2013;5: 095-098.
- Gnana Raja M,  et al. Simultaneous, Stability Indicating Method Development and Validation for  Related Compounds of Ibuprofen and Paracetamol Tablets by RP-HPLC Method. J  Chromat Separation Techniq. 2012;3:155.
- Ansary A, et  al. Simultaneous Determination of Carvedilol and Hydrochlorothiazide in Tablets  and Spiked Human Plasma using Derivative Spectrophotometry. Pharmaceut Anal  Acta. 2012;3:186.
- Ahir KB, et  al.  Simultaneous Estimation of Nebivolol  Hydrochloride and Hydrochlorothiazide in Tablets by TLC-Densitometry. J Chromat  Separation Techniq. 2012;3:141.
- Ratnaparkhi  MP. Formulation and Development of Taste Masked Orally Disintegrating Tablets  of Perindopril Erbumine by Direct Compression Method. Pharmaceut Anal Acta.  2012;3:162.
- Jagadeeswaran  M, et al. Quantitative Estimation of Lopinavir and Ritonavir in Tablets by  RP-HPLC Method. Pharmaceut Anal Acta. 2012;3:160.
- Zou JJ, et  al. Bioequivalence Study of Clopidogrel 75 Mg Tablets in Healthy Male  Volunteers. J Bioequiv Availab.2012;4: 006-009.
- César IC, et  al. Bioequivalence Study of Two Oral Formulations of Memantine Tablets in  Healthy Brazilian Volunteers after a Single Dose Administration. J  BioequivAvailab. 2012;4: 014-017.
- Ruiz A, et  al. Bioequivalence Evaluation of Two Formulations of Lamotrigine Tablets in  Healthy Volunteers. J BioequivAvailab. 2012;4: 030-034.
- Usman M, et  al. Preparation and Evaluation of Controlled Release Tablets Containing  Mefenamic Acid. ClinExpPharmacol. 2012;2:107.
- Qiu X, et al.  Pharmacokinetics and BioequivalenceEvaluation of Two Voriconazole tablets: an  Open-Label, Single-Dose, Randomized, Two-Way Crossover Study in Healthy Chinese  Male Volunteers. J Bioequiv Availab.2012;4: 044-047.
- Nanjwade BK,  et al. Development and Evaluation of Gastroretentive Floating Tablets of  Glipizide Based on Effervescent Technology. J Drug Metab Toxicol.2012;3:121.
- Babu B, et  al. Pharmacokinetic Evaluation of Metolazone Tablets using Healthy Human  Volunteers. J BioequivAvailab. 2010;2:015-017.
- Khattak S, et  al. Comparative Bioavailability Assessment of Newly Developed Flurbiprofen  Matrix Tablets and Froben SR® Tablets in Healthy Pakistani Volunteers. J  BioequivAvailab. 2010;2: 139-144.
- De Caro V, et  al. Galantamine Delivery on Buccal Mucosa: Permeation Enhancement and Design of  Matrix Tablets. J BioequivAvailab. 2009;1:127-134.
- Bari SB, et  al. Application of UV Spectroscopy and First Order Derivative Method for  Determination of Tamsulosin Hydrochloride in Bulk and Tablets. Pharm Anal Acta.  2011;2:120.
- Chatsiricharoenkul  S, et al. Bioequivalence Study of 10 mg Olanzapine Tablets in Healthy Thai  Volunteers. J BioequivAvailab. 2011;3:082-085.
- Patel BDet  al. Quantification of Newer Anti-Cancer Drug Clofarabine in their Bulk and  Pharmaceutical Dosage Form. J Chromatogr Sep Tech.2016;7:328.
- Permender R,  et al. Novel Statistically Designed Qbd Methodology for Quantitative Analysis  of Nisoldipine in Pharmaceutical Dosage Forms. Pharm Anal Acta.2016;7:489.
- Naveed S, et  al. Stability of a Dosage Form and Forced Degradation Studies. J  BioequivAvailab. 2016;8:191-193.
- Vadlamudi MK  and Dhanaraj S. Stability Indicating Method for the Determination of Related  Substances in Felodipine Solid Dosage Form and in the Drug Substance by  RP-HPLC. J BioequivAvailab. 2016;8:153-166.
- Naveed S, et  al. UV Spectrophotometric Method for Estimation of Ofloxacin in Tablet Dosage  Form and Comparative Study of its Two Brands. J BioequivAvailab.  2016;8:125-127.
- Sharma H.  Regulatory Inspection of Clinical Trials. PharmaceuticRegulat  Affair.2012;1:e103.
- Swain S.  Responsibility of Regulatory Affairs in Pharmaceutical Industry.  PharmaceuticRegulat Affair.2012;1:e104.
- Hammouda EI  and Hammouda SE. Outpatient Ambulatory Pharmacy; an Innovation in Dispensing  System to Optimize Performance and Meet Standards. PharmaceuticRegulat  Affair.2012;1:101.
- Minghetti P  and Selmin F. How to Meet Legitimate Expectations of Patients when Authorized  Medicinal Products are not Available. PharmaceutReg Affairs. 2012;1:e108.